World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
47
Citations
9251
World Ranking
4506
National Ranking
2037

Overview

Charles H. Hoke is affiliated with the Walter Reed Army Institute of Research, a prominent biomedical research facility in the United States. The association with this institution situates their work within a context focused on military medical research and related scientific inquiries.

The available information does not list specific publications authored by Charles H. Hoke. Consequently, details such as paper titles, years of publication, and venues are not provided, which limits insight into recent contributions to scientific literature.

There are no recorded frequent co-authors connected to Charles H. Hoke. Similarly, no data is available regarding regular publication venues, which means there is no indication of recurring journals or conferences in which this scientist publishes.

Information about book publications is also absent, so it is not known whether Charles H. Hoke has authored or contributed to academic books or monographs available through recognized publishers.

The data does not specify primary fields of study, subfields, or main research topics linked to this scientist. This lack of detailed topic metadata prevents an assessment of the particular scientific domains or specialties they may focus on.

No awards or honors have been recorded in this dataset for Charles H. Hoke, and the scientist is not noted as deceased. The absence of such information may indicate either a lack of publicly known accolades or that this data has not been documented here.

Best Publications

  • Estimated global incidence of Japanese encephalitis: a systematic review

    Grant L Campbell;Susan L Hills;Marc Fischer;Julie A Jacobson

  • An enzyme-linked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis co-circulate.

    B. L. Innis;A. Nisalak;S. Nimmannitya;S. Kusalerdchariya

  • Protection against Japanese Encephalitis by Inactivated Vaccines

    C H Hoke;A Nisalak;N Sangawhipa;S Jatanasen

  • SEROTYPE-SPECIFIC DENGUE VIRUS CIRCULATION AND DENGUE DISEASE IN BANGKOK, THAILAND FROM 1973 TO 1999

    Ananda Nisalak;Timothy P. Endy;Suchitra Nimmannitya;Siripen Kalayanarooj

  • Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers

    N. Kanesa-thasan;W. Sun;G. Kim-Ahn;S. Van Albert

  • Japanese encephalitis: immunocytochemical studies of viral antigen and inflammatory cells in fatal cases.

    Richard T. Johnson;Donald S. Burke;Michael Elwell;Colin J. Leake

  • Infectious Japanese encephalitis virus RNA can be synthesized from in vitro-ligated cDNA templates.

    Hideo Sumiyoshi;Charles H. Hoke;Dennis W. Trent

  • Sensitivity and specificity of a universal primer set for the rapid diagnosis of dengue virus infections by polymerase chain reaction and nucleic acid hybridization.

    Erik A. Henchal;Stephanie L. Polo;Vance Vorndam;Chandhana Yaemsiri

  • Effect of High-Dose Dexamethasone on the Outcome of Acute Encephalitis Due to Japanese Encephalitis Virus

    Charles H. Hoke;David W. Vaughn;Ananda Nisalak;Pensri Intralawan

  • Development of a Purified, Inactivated, Dengue-2 Virus Vaccine Prototype in Vero Cells: Immunogenicity and Protection in Mice and Rhesus Monkeys

    Robert Putnak;David A. Barvir;Jeanne M. Burrous;Doria R. Dubois

  • Human T cell responses to dengue virus antigens. Proliferative responses and interferon gamma production.

    Ichiro Kurane;Bruce L. Innis;Ananda Nisalak;Charles H. Hoke

  • Vaccination of human volunteers with monovalent and tetravalent live-attenuated dengue vaccine candidates.

    Wellington Sun;Robert Edelman;Niranjan Kanesa-Thasan;Kenneth H. Eckels

  • Fatal outcome in Japanese encephalitis.

    Donald S. Burke;Wanida Lorsomrudee;Colin J. Leake;Charles H. Hoke

  • Testing of a dengue 2 live-attenuated vaccine (strain 16681 PDK 53) in ten American volunteers

    David W. Vaughn;Charles H. Hoke;Sutee Yoksan;Rebecca LaChance

  • Molecular characterization of a neutralizing domain of the Japanese encephalitis virus structural glycoprotein.

    P. W. Mason;J. M. Dalrymple;M. K. Gentry;J. M. McCown

  • Safety and immunogenicity of NYVAC-JEV and ALVAC-JEV attenuated recombinant Japanese encephalitis virus--poxvirus vaccines in vaccinia-nonimmune and vaccinia-immune humans.

    Niranjan Kanesa-thasan;John J. Smucny;Charles H. Hoke;Donald H. Marks

  • Mice immunized with a dengue type 2 virus E and NS1 fusion protein made in Escherichia coli are protected against lethal dengue virus infection

    Ashok Kumar Srivastava;Joseph Robert Putnak;Richard Lloyd Warren;Charles Hearn Hoke

  • Dengue virus type 2 vaccine: reactogenicity and immunogenicity in soldiers

    W. H. Bancroft;R. M. Scott;K. H. Eckels;C. H. Hoke

  • A live attenuated dengue-1 vaccine candidate (45AZ5) passaged in primary dog kidney cell culture is attenuated and immunogenic for humans.

    Robert Edelman;Carol O. Tacket;Steven S. Wasserman;David W. Vaughn

  • History of the restoration of adenovirus type 4 and type 7 vaccine, live oral (Adenovirus Vaccine) in the context of the Department of Defense acquisition system.

    Charles H. Hoke;Clifford E. Snyder

  • Infection of Owl Monkeys (Aotus trivirgatus) and Cynomolgus Monkeys (Macaca fascicularist) with Hepatitis E Virus from Mexico

    John Ticehurst;John Ticehurst;John Ticehurst;Lowrey L. Rhodes;Krzysztof Krawczynski;Krzysztof Krawczynski;Krzysztof Krawczynski;Ludmila V.S. Asher;Ludmila V.S. Asher;Ludmila V.S. Asher

Frequent Co-Authors

Bruce L. Innis
Bruce L. Innis GlaxoSmithKline (United Kingdom)
David W. Vaughn
David W. Vaughn Bill & Melinda Gates Foundation
Ananda Nisalak
Ananda Nisalak United States Department of the Army
Donald S. Burke
Donald S. Burke University of Pittsburgh
Kenneth H. Eckels
Kenneth H. Eckels Walter Reed Army Institute of Research
Ichiro Kurane
Ichiro Kurane National Institutes of Health
Francis A. Ennis
Francis A. Ennis University of Massachusetts Chan Medical School
Robert R. Edelman
Robert R. Edelman Northwestern University
Anthony A. Marfin
Anthony A. Marfin A2M Epidemiology
Richard T. Johnson
Richard T. Johnson Johns Hopkins University School of Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, pursuing related nursing degrees such as Nurse Practitioner (NP) programs can open diverse healthcare career opportunities. If you’re seeking a program with less intensive requirements, exploring what is the easiest np program can provide insights into more accessible pathways to advanced practice nursing roles.

Psychiatric Mental Health Nurse Practitioner (PMHNP) programs are particularly relevant for professionals aiming to specialize in mental health and immunological impacts on psychiatric conditions. The top online pmhnp programs offer strong clinical placement rates, ensuring valuable hands-on experience crucial for career success.

Affordability is another important factor when choosing an online degree. Prospective students should consider the cheapest psych np programs to balance quality education with financial feasibility, especially when planning long-term career paths in immunology-adjacent healthcare fields.

Understanding compensation after degree completion is essential. Salary transparency, such as available through resources detailing the dnp salary transparency, helps graduates make informed decisions about their investment in advanced practice degrees and potential earnings in different states.

Best Scientists Citing Charles H. Hoke

Recently Published Articles